insights_auto
Nega TAKP34 tushdi 7,40%?
Batafsil oʻrganishchevron_right
TAKP34:BVMF
Takeda Pharmaceutical Co Ltd BDR
90,54 R$
arrow_downward
-7,40%(-7,23) 1K
6-okt, 15:21:39 (GMT-3) · BRL
search
Barcha belgilar
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_autoTAKP34 tikeri uchun statistika yaratilmoqda...
Ochish
102,65 R$
Yuqori
102,65 R$
Past
90,00 R$
Bozor kapitali
58,29 mlrd
Oʻrtacha hajm
36,00
Hajmi
3,00
52 haftalik eng yuqori
102,65 R$
52 haftalik eng past
70,80 R$
Muomaladagi aksiyalar
1,60 mlrd
Xodimlar soni
47 ming
Ochish
102,65 R$
Yuqori
102,65 R$
Past
90,00 R$
Bozor kapitali
58,29 mlrd
Oʻrtacha hajm
36,00
Hajmi
3,00
52 haftalik eng yuqori
102,65 R$
52 haftalik eng past
70,80 R$
Muomaladagi aksiyalar
1,60 mlrd
Xodimlar soni
47 ming
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
Simply Wall Street
·
2 daqiqa oldin
Should Phase 3 Psoriasis Win Require Action From Takeda Stock Investors?
AD HOC NEWS
·
1 soat oldin
Takeda stock after-hours: prior close at EUR 15.55
AD HOC NEWS
·
23 soat oldin
Takeda partners with Innovent: what USD 1.20 billion means for Innovent Biologics stock
TipRanks
·
1 kun oldin
Takeda’s GATTEX Safety Survey Update: What Investors Should Watch
Profil
The Takeda Pharmaceutical Company Limited is a Japanese multinational pharmaceutical company. It is the third largest pharmaceutical company in Asia, behind Sinopharm and Shanghai Pharmaceuticals, and one of the top 20 largest pharmaceutical companies in the world by revenue. The company has over 49,578 employees worldwide and achieved US$19.299 billion in revenue during the 2018 fiscal year. The company is focused on oncology, rare diseases, neuroscience, gastroenterology, plasma-derived therapies and vaccines. Its headquarters is located in Chuo-ku, Osaka, and it has an office in Nihonbashi, Chuo, Tokyo. In January 2012, Fortune Magazine ranked the Takeda Oncology Company as one of the 100 best companies to work for in the United States. As of 2015, Christophe Weber was appointed as the CEO and president of Takeda. In 2026, Julie Kim was noted in a news item as "CEO-elect". Wikipedia
Takeda Pharmaceutical Co Ltd BDR haqida
CEOChristophe Weber | Christophe Weber
Xodimlar soni47 ming
Asos solingan12-iyn, 1781
Bosh ofislar-
Sektor-
Veb-sayttakeda.com